Bacterial strains and use thereof in fermentation processes...

Details Bacterial strains and use thereof in fermentation processes... Bacterial strains and use thereof in fermentation processes...

2000-10-10

2003-04-01

Ketter, James (Department: 1636)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S041000, C435S471000, C435S476000

Reexamination Certificate

active

06541239

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to a process for the production of 2-keto-L-gulonic acid by fermentative conversion of L-sorbose and/or D-sorbitol. The present invention further relates to novel bacterial strains useful in this process.
BACKGROUND OF THE INVENTION
2-Keto-L-gulonic acid (“2-KLG”) is a significant intermediate in the preparation of L-ascorbic acid (vitamin C), an essential nutrient. 2-KLG has been synthesized in the past on an industrial scale using the Reichstein method (
Helvetica Chimica Acta
17:311 (1934)). This method, however, has a number of disadvantages for commercial application, including the use of large quantities of solvents and the involvement of a number of complex reaction steps.
Accordingly, as an alternative to the Reichstein method, a number of processes employing one or more microorganisms have been developed to produce 2-KLG by fermentation. U.S. Pat. No. 2,421,611, for example, discloses a method involving microbial oxidation of D-glucose to 5-keto-D-gluconic acid, followed by chemical or microbial reduction to L-idonic acid and subsequent microbial oxidation to 2-KLG. Japanese Patent Publication Nos. 39-14493, 53-25033, 56-15877 and 59-35290, for example, disclose similar processes involving the microbial oxidation of D-glucose to 2,5-diketo-D-gluconic acid followed by microbial or chemical reduction to 2-KLG.
These methods, however, also suffer from a number of disadvantages that reduce their usefulness in commercial production of 2-KLG. For example, the chemical reduction steps in these methods (i.e. the reduction of 5-keto-D-gluconic acid to L-idonic acid and 2,5-diketo-D-gluconic acid to 2-KLG) are accompanied by problems with controlling the stereochemistry of reduction (thus producing D-gluconic acid and 2-keto-D-gluconic acid, respectively, as byproducts) which, in turn, reduces the yield of 2-KLG. Alternatively, when this reduction is performed by one or more microorganisms, excess sugar is required to provide an energy source for the reduction, which also reduces the yield of 2-KLG.
In view of these problems, an alternate pathway has been employed for the fermentative production of 2-KLG, which involves only oxidation of L-sorbose to 2-KLG via a sorbosone intermediate. A number of processes have been developed using this pathway that employ a wide range of microorganisms from the genera Gluconobacter, such as
Gluconobacter oxydans
(U.S. Pat. Nos. 4,935,359; 4,960,695; 5,312,741; and 5,541,108), Pseudogluconobacter, such as
Pseudogluconobacter saccharoketogenes
U.S. Pat. Nos. 4,877,735; European Patent No. 221 707), Pseudomonas, such as
Pseudomonas sorbosoxidans
(U.S. Pat. Nos. 4,933,289 and 4,892,823), and mixtures of microorganisms from these and other genera, such as Acetobacter, Bacillus, Serratia, Mycobacterium, and Streptomyces (U.S. Pat. Nos. 3,912,592; 3,907,639; and 3,234,105).
These processes, however, suffer from certain disadvantages that limit their usefulness for commercial production of 2-KLG. For example, the processes referenced above that employ
G. oxydans
also require the presence of an additional “helper” microbial strain, such as
Bacillus megaterium,
or commercially unattractive quantities of yeast or growth components derived from yeast in order to produce sufficiently high levels of 2-KLG for commercial use. Similarly, the processes that employ Pseudogluconobacter can require medium supplemented with expensive and unusual rare earth salts or the presence of a helper strain, such as
B. megaterium,
and/or the presence of yeast in order to achieve commercially suitable 2-KLG concentrations and efficient use of sorbose substrate. Other processes that employ
Pseudomonas sorbosoxidans
also include commercially unattractive qualities of yeast or yeast extract in the medium.
Accordingly, there is a need in the art for microorganism strains which efficiently produce 2-KLG, but without many of the problems associated with the state of the art.
SUMMARY OF THE INVENTION
It is therefore an object of the present invention to provide microorganism strains which efficiently produce 2-KLG. Other objects, features and advantages of the present invention will be set forth in the detailed description of preferred embodiments that follows, and in part will be apparent from the description or may be learned by practice of the invention. These objects and advantages of the invention will be realized and attained by the methods particularly pointed out in the written description and claims hereof.
These and other objects are accomplished by the methods of the present invention, which, in a first embodiment, is directed to a process for producing 2-KLG from L-sorbose, which comprises the steps of culturing in a medium a microorganism of strain NRRL B-21627 (ADM X6L) or a mutant or variant thereof, either alone or in mixed culture with one or more helper strains, and then recovering the accumulated 2-KLG. Another embodiment of the present invention is directed to a culture of a microorganism of strain NRRL B-21627 or a mutant thereof, such as NRRL B-21630 (ADM 86-96).
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are intended to provide further explanation of the invention as claimed.


REFERENCES:
patent: 2421611 (1947-06-01), Gray
patent: 3043749 (1962-07-01), Huang
patent: 3234105 (1966-02-01), Motizuki et al.
patent: 3907639 (1975-09-01), Makover et al.
patent: 3912592 (1975-10-01), Makover et al.
patent: 4876195 (1989-10-01), Shirafuji et al.
patent: 4877735 (1989-10-01), Nogami et al.
patent: 4892823 (1990-01-01), Imai et al.
patent: 4933289 (1990-06-01), Imai et al.
patent: 4935359 (1990-06-01), Yin et al.
patent: 4945048 (1990-07-01), Uchihori et al.
patent: 4960695 (1990-10-01), Hoshino et al.
patent: 4994382 (1991-02-01), Ameyama et al.
patent: 5082785 (1992-01-01), Manning et al.
patent: 5312741 (1994-05-01), Hoshino et al.
patent: 5344768 (1994-09-01), Urakami
patent: 5399496 (1995-03-01), Fujiwara et al.
patent: 5437989 (1995-08-01), Asakura et al.
patent: 5474924 (1995-12-01), Nogami et al.
patent: 5541108 (1996-07-01), Fujiwara et al.
patent: 5580782 (1996-12-01), Beppu et al.
patent: 5834231 (1998-11-01), Stoddard et al.
patent: 5989891 (1999-11-01), Liaw et al.
patent: 6127156 (2000-10-01), Hoshino et al.
patent: 6127174 (2000-10-01), Tonouchi et al.
patent: 6316231 (2001-11-01), Stoddard et al.
patent: 6319699 (2001-11-01), Stoddard et al.
patent: 1081470 (1994-02-01), None
patent: 0 206 471 (1986-12-01), None
patent: 0 213 591 (1987-03-01), None
patent: 0 221 707 (1987-05-01), None
patent: 0 276 832 (1988-08-01), None
patent: 0 278 447 (1988-08-01), None
patent: 0 381 027 (1990-08-01), None
patent: 0 518 136 (1992-12-01), None
patent: 0 832 974 (1998-01-01), None
patent: 1 076 094 (2001-02-01), None
patent: 41-159 (1966-01-01), None
patent: 41-160 (1966-01-01), None
patent: 41-5907 (1966-03-01), None
patent: 51-40154 (1976-04-01), None
patent: 59-113896 (1984-06-01), None
patent: 03-294281 (1991-12-01), None
patent: 07-67673 (1995-03-01), None
patent: 7-250671 (1995-10-01), None
patent: 08-245702 (1996-09-01), None
patent: 526660 (1976-10-01), None
patent: WO 98/17819 (1998-04-01), None
patent: WO 98/33885 (1998-08-01), None
patent: WO 00/15827 (2000-03-01), None
Kieslich, K., volume ed., “Biotransformations,”Biotechnology 6A:436-437, Verlag Chemie (1934).
Tsukada, Y. and Perlman, D., “The Fermentation of L-Sorbose byGluconobacter melanogenus. I. General Characteristics of the Fermentation,”Biotechnology and Bioengineering XIV:799-810, John Wiley & Sons, Inc. (1972).
Yin, G.-L. et al., “Studies on the Production of Vitamin C Precursor 2-Keto-L-Gluconic Acid from L-Sorbose by Fermentation. I. Isolation, Screening and Identification of 2-Keto-L-Gluconic Acid Producing Bacteria,”Acta Microbiologica Sinica 20:246-251, Weishengwu Xuebao (1980).
English Translation of Yin, G.-L. et al., “Studies on the Production of Vitamin C Precursor 2-Keto-L-Gluconic Acid from L-Sorbose by Fermentatio

Affiliated with

Also associated with

Rating

Bacterial strains and use thereof in fermentation processes... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bacterial strains and use thereof in fermentation processes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacterial strains and use thereof in fermentation processes... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3076300